Cargando…

Treatment-Resistant Depression – What is the Effective Maintenance Treatment

INTRODUCTION: Treatment-resistant depression (TRD) presents a significant challenge in clinical practice. Besides antidepressant medications, neurostimulation methods (ECT, rTMS) and ketamine are viable treatment options. OBJECTIVES: To objectively evaluate the real effectiveness of treatments withi...

Descripción completa

Detalles Bibliográficos
Autor principal:	Kolar, D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567018/ http://dx.doi.org/10.1192/j.eurpsy.2022.1422

Ejemplares similares

Vns as alternative treatment for maintenance ect in a patient with treatment resistant depression - a case study
por: Migchels, C., et al.
Publicado: (2021)

Effects of psilocybin-assisted therapy on treatment-resistant depression
por: Fraga, A., et al.
Publicado: (2021)

Suicidality in Treatment-Resistant Depression Patients
por: Lyubov, E. B., et al.
Publicado: (2023)

How effective are ketamine or esketamine in treatment-resistant depression?
por: Veluri, N., et al.
Publicado: (2021)

Is treatment resistant depression a different subtype of depression?
por: Fiorillo, A.
Publicado: (2021)

The role of intranasal esketamine in treatment-resistant depression
por: Fraga, A., et al.
Publicado: (2021)

PS142. Ketamine is effective in an animal model of treatment resistant depression
por: Pereira, Vitor Silva, et al.
Publicado: (2016)

PS87. An update on prediction of treatment outcome in treatment resistant depression
por: Kautzky, Alexander, et al.
Publicado: (2016)

The effect of aerobic exercise in the maintenance treatment of depression
por: Majumder, P., et al.
Publicado: (2015)

Effectiveness and Tolerability of Intranasal Esketamine in Treatment-Resistant Depression: Report of Two Clinical Cases
por: Mercado-Rodríguez, A., et al.
Publicado: (2023)

Proposal of a therapeutic algorithm for the psychopharmacological management of treatment-resistant depression
por: Sanz Giancola, A., et al.
Publicado: (2022)

PSYCHOLOGICAL WELL-BEING IN OLDER ADULTS WITH TREATMENT-RESISTANT DEPRESSION
por: Kallmi, Selmi, et al.
Publicado: (2022)

Healthcare costs and productivity losses in treatment-resistant depression in Finland
por: Rannanpää, S., et al.
Publicado: (2022)

PS193. MicroRNAs as biomarkers for treatment-resistant depression
por: Gururajan, A, et al.
Publicado: (2016)

Vagus nerve stimulation in treatment-resistant depression. Long-term clinical outcomes
por: Rosson, S., et al.
Publicado: (2021)

PS135. Effects of the mineralocorticoid receptor antagonist spironolactone in a treatment-resistant model of depression in female rats
por: Hlavacova, N, et al.
Publicado: (2016)

Nitrous Oxide in Treatment Resistant Major Depression: Should We Laugh About It?
por: Leal, B., et al.
Publicado: (2022)

Bipolar mood disorder and treatment-resistant depression
por: Rybakowski, Janusz K
Publicado: (2010)

Clinical stability after compassionate use of intranasal esketamine in treatment-resistant depression
por: Hernandez Huerta, D., et al.
Publicado: (2022)

Polyunsaturated fatty acid in treatment resistant depression: A pilot study
por: Jannini, T., et al.
Publicado: (2021)

Role of Repetitive Transcranial Magnetic Stimulation in Maintenance Treatment of Resistant Depression
por: Chatterjee, Biswadip, et al.
Publicado: (2012)

Efficacy of maintenance electroconvulsive therapy in recurrent depression: a case series
por: Guerra Valera, G., et al.
Publicado: (2023)

Acute and Maintenance Treatment of Bipolar Depression
por: ERTEN, Evrim
Publicado: (2021)

The effect of antidepressant treatment on white matter integrity in Major Depression
por: Tourjman, S., et al.
Publicado: (2022)

Use of pharmacotherapies for treatment resistant depression in finland: A nationwide cohort study
por: Taipale, H., et al.
Publicado: (2021)

The Application of Deep Brain Stimulation for Treatment-Resistant Depression – A Narrative Review
por: Wellington, J., et al.
Publicado: (2023)

Long-acting new generation antipsychotics in the maintenance treatment of bipolar disorders
por: Yavuz, E., et al.
Publicado: (2022)

Long-acting new generation antipsychotics in the maintenance treatment of bipolar disorders
por: Yavuz, E., et al.
Publicado: (2023)

What’s new on the treatment of pedophilia and hebephilia?
por: Castro Rodrigues, J., et al.
Publicado: (2023)

What is special about suicidal depression?
por: Courtet, P., et al.
Publicado: (2021)

Maintenance use of ketamine for treatment-resistant depression: an open-label pilot study
por: Barenboim, Ivan, et al.
Publicado: (2018)

Efficacy and safety of intermittent theta burst stimulation (iTBS) in treatment resistant depression
por: Kavakbasi, E., et al.
Publicado: (2022)

Esketamine in patient with treatment resistant depression: Outcome of the temporary authorization for use programme in France
por: Wattinne, E. Gaudre, et al.
Publicado: (2021)

Patient’s perspective on early treatment retention in take home buprenorphine maintenance treatment- an explorative study from India
por: M, P., et al.
Publicado: (2021)

Medication adherence in the treatment of depression
por: Pejuskovic, B., et al.
Publicado: (2023)

The efficacy psychobiotics for depression treatment
por: Denysov, Y., et al.
Publicado: (2023)

S236. IS MAINTENANCE TREATMENT NEEDED WHEN THE FIRST EPISODE OF PSYCHOSIS IS NOT DUE TO SCHIZOPHRENIA?
por: Odejayi, Gbolahan, et al.
Publicado: (2018)

PS37. Lurasidone in the Treatment of Bipolar Depression: Effect of Baseline Depression Severity on Clinical Outcome
por: Pikalov, Andrei, et al.
Publicado: (2016)

Addictive potential of novel treatments for refractory depression and anxiety
por: Kolar, Dusan
Publicado: (2018)

The use of light, temperature and pressure in the treatment of depression
por: Zalewski, D., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cb8tsika70ffrahra4jautk5qk